Neurorehabilitation and Neural Repair

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuan, W. -L.
Right arrow Articles by Barker, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuan, W. -L.
Right arrow Articles by Barker, R. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Neurorehabilitation and Neural Repair, Vol. 19, No. 3, 155-181 (2005)
DOI: 10.1177/1545968305277219


Reviews

New Therapeutic Approaches to Parkinson’s Disease Including Neural Transplants

W. -L. Kuan

Cambridge Centre for Brain Repair

R. A. Barker

Cambridge Centre for Brain Repair, Department of Neurology, Cambridge University, Cambridge, UK, Edith Cowan University, Perth, Australia, rab46{at}hermes.cam.ac.uk

Parkinson’s disease (PD) is a common neurodegenerative disorder of the brain and typically presents with a disorder of movement. The core pathological event underlying the condition is the loss of the dopaminergic nigrostriatal pathway with the formation of alpha-synuclein positive Lewy bodies. As a result, drugs that target the degenerating dopaminergic network within the brain work well at least in the early stages of the disease. Unfortunately, with time these therapies fail and produce their own unique side-effect profile, and this, coupled with the more diffuse pathological and clinical findings in advancing disease, has led to a search for more effective therapies. In this review, the authors will briefly discuss the emerging new drug therapies in PD before concentrating on a more detailed discussion on the state of cell therapies to cure PD.

Key Words: Parkinson’s disease • Drug therapies • Cell transplantation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Neurorehabil Neural RepairHome page
S. Onla-or and C. J. Winstein
Determining the Optimal Challenge Point for Motor Skill Learning in Adults With Moderately Severe Parkinson's Disease
Neurorehabil Neural Repair, July 1, 2008; 22(4): 385 - 395.
[Abstract] [PDF]